Evidence map›Paper›PMID 41036686›Full record

Trial reportJournal of cachexia, sarcopenia and muscle2025

Resistance Exercise Intervention Restores Functional Capacity and Improves Frailty Biomarkers in Centenarians.

Diego Marcos-Perez, Adrián Hernandez-Vicente, Sara Cruces-Salguero, Jon Landa, Michelle Bonvini, German Vicente-Rodríguez, Esther Pueyo, Leocadio Rodriguez-Mañas, Pedro Abizanda, David Otaegui and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of cachexia, sarcopenia and muscle, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Diego Marcos-PerezCellular Oncology Group, Biodonostia (Biogipuzkoa) Health Research Institute, San Sebastián, Spain.
Adrián Hernandez-VicenteGrowth, Exercise, Nutrition and Development (GENUD) Research Group, University of Zaragoza, Zaragoza, Spain.
Sara Cruces-SalgueroCellular Oncology Group, Biodonostia (Biogipuzkoa) Health Research Institute, San Sebastián, Spain.
Jon LandaCellular Oncology Group, Biodonostia (Biogipuzkoa) Health Research Institute, San Sebastián, Spain.
Michelle BonviniCellular Oncology Group, Biodonostia (Biogipuzkoa) Health Research Institute, San Sebastián, Spain.
German Vicente-RodríguezGrowth, Exercise, Nutrition and Development (GENUD) Research Group, University of Zaragoza, Zaragoza, Spain.
Esther PueyoBSICoS Group, I3A, IIS Aragón, Universidad de Zaragoza, Zaragoza, Spain.
Leocadio Rodriguez-MañasGeriatrics Department, Getafe University Hospital, Getafe, Spain.
Pedro AbizandaCentro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.
David OtaeguiNeuroimmunology Group, Biodonostia (Biogipuzkoa) Health Research Institute, San Sebastián, Spain.
Nuria GaratacheaGrowth, Exercise, Nutrition and Development (GENUD) Research Group, University of Zaragoza, Zaragoza, Spain.
Ander MatheuCellular Oncology Group, Biodonostia (Biogipuzkoa) Health Research Institute, San Sebastián, Spain.ORCID 0000-0002-1848-0781

Funding

Agencia Estatal de Investigación - Ministerio de Ciencia e Innovación PID2022-140556OB-I00Agencia Estatal de Investigación - Ministerio de Ciencia e Innovación TED2021-130459BI00Carlos III Institute of Health and the European Regional Development Fund DTS20/00179Carlos III Institute of Health and the European Regional Development Fund PI19/01355Carlos III Institute of Health and the European Regional Development Fund PI22/01905CIBERFES, Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, España, Ayuda cofinanciada por el Fondo Europeo de Desarrollo Regional FEDER Una Manera de hacer Europa CB16/10/00408CIBERFES, Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, España, Ayuda cofinanciada por el Fondo Europeo de Desarrollo Regional FEDER Una Manera de hacer Europa CB16/10/00464CIBERFES, Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, España, Ayuda cofinanciada por el Fondo Europeo de Desarrollo Regional FEDER Una Manera de hacer Europa CB16/10/00496FPUFundación Científica Asociación Española Contra el CáncerGobierno de Aragón T39_23R groupHealth Department of the Basque Country 2022333016Health Department of the Basque Country 2023333055Ministerio de Economía, Industria y Competitividad DEP2016-78309-RMinisterio de Educación Cultura y Deporte FPU16/05879Sara Borrell CD21/00117
6 · The paper itself

Abstract

backgroundCentenarians comprise an age group characterized by exceptional longevity and low age-associated pathologies. However, they still experience physiological decline, and different studies have linked frailty to this population. Exercise interventions reverse frailty and improve functional capacity, but no studies have addressed the effect of an intervention in centenarians. In this study, we assessed the impact of a 12-week resistance exercise intervention in a group of centenarians and characterized their functional capacity as well as the expression of several molecular biomarkers associated with frailty.

methodsA total of 19 centenarians were enrolled, but 7 of them did not complete the study. The remaining 12 centenarians were randomly assigned to the control or intervention group, which was a 12-week resistance exercise intervention. Molecular biomarkers were measured by qRT-PCR and ELISA.

resultsThe intervention group improved their functional capacity measured by Short Physical Performance Battery (SPPB) (post 5.0 vs 2.3 in pre) and Physical Performance and Mobility Examination (PPME) (6.5 vs 3.8), as well as in frailty status studied by Fried Frailty Phenotype (3.0 vs 3.8) and Frailty Trait Scale 5 (FTS5) (post 30.7 vs 34.0 in pre) scales. ANCOVA revealed that the resistance training led to significant improvements in functional capacity scales SPPB (p = 0.01) and PPME (p < 0.001), as well as Fried Frailty Phenotype (p = 0.001) and FTS5 (p = 0.05). Biomarkers related to frailty (EGR1, miR194-5p, miR125b-5p and miR454-3p) and inflammation (IL-6 and IL-1β) showed different expression patterns in centenarians (n = 19) compared to both old (n = 44, average of 79 years old) and young adults (n = 34, average of 29 years old) groups. Notably, the intervention was associated with improvements in frailty and inflammation biomarkers expression. Finally, correlation analyses showed significant associations between all functional and frailty variables, with SPPB correlating with miR454-3p (ρ = 0.73) and FTS5 correlating with miR454-3p (ρ = -0.83), IL-6 (ρ = 0.60) and miR125b-5p (ρ = -0.55).

conclusionsOur results revealed that resistance exercise intervention enhances functional status and reduces frailty in centenarians, and this is associated with improvements in frailty and inflammation biomarkers.

Indexed as

BiomarkersFrailtyResistance TrainingAged, 80 and overFemaleHumansMaleBiomarkerscentenariansfrailtymolecular biomarkersresistance exercise

Identifiers

PMID41036686
PMCPMC12489740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.